Management of lipids in the elderly

Anderson KM , Castelli WP , Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987; 257: 2176–80.

Mann JI , Lewis B , Shepherd J , Winder AF , Fenster S , Rose L , Morgan B. Blood lipids and other cardiovascular risk factors; their prevalence in Britain. BMJ 1988; 296: 1702–6.

Winder AF , Jagger C , Garrick DP Lipid screening in an elderly population. Difficulty in interpretation and in detection of occult metabolic disease. J Clin Pathol 1996; 49: 278–83.

Roussow JE , Van Staden DA , Benade AJS Is it normal for serum cholesterol to rise with age? In: Fidge NH , Nestel PJ , eds. Atherosclerosis VII. Amsterdam: Excerpta Medica, 1986: 37–40.

Weintraub M , Ringel Y , Rassin T , Arad J , Bodner G , Liron M. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis. J Gerontol 1992; 47: B209–13.

Gylling H , Strandberg T , Tilvis R , Miettinen TA . Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism. Art Thromb 1994; 14: 694–700.

Pocock SJ , Seed PT . Cholesterol in elderly women. Lancet 1992; 339: 1426.

Berg K , Ro OC . Lp(a) lipoprotein and longevity. Ann Genet 1991; 34: 264–9.

The Expert Panel: summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269: 3015–23.

Betteridge DJ , Dodson PM , Hughes EA Management of hyperlipidaemia—guidelines of the British Hyperlipidaemia Association. Postgrad Med J 1993; 69: 359–69.

Zimetbaum P , Frischman WH , Ooi WL Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Ageing Study. Art Thromb 1992; 12: 416–23.

Reed D , Benfante R. Lipid and lipoprotein predictors of coronary heart disease in elderly men in the Honolulu Heart Program. Ann Epidemiol 1992; 2: 29–34.

Barrett-Connor E. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women: The Rancho Bernado Study. Ann Epidemiol 1992; 2: 77–83.

Bass KM , Newschaffer CJ , Klag MJ , Bush TL . Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993; 153: 2209–16.

Frischman WH , Ooi WL , Derman MP Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol 1992; 21: 43–50.

Weverling-Rijnsberger AWE , Blauw G , Lagaay AM , Knook D , Meinders AE . Total cholesterol and risk of mortality in the oldest old. lancet 1997; 350: 1119–23.

Iribarren C , Reed DM , Chen RC , Yano K , Dwyer JH . Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 1995; 92: 2396–403.

Jagger C , Clarke M , Clarke SJ . Getting older—feeling younger: the changing health profile of the elderly. Int J Epidemiol 1991; 20: 234–8.

Evans P , Pereira Grey D. Value of screening for secondary causes of hyperlipidaemia in general practice. BMJ 1994; 309: 509–10.

Nawawi H , Day LB , Mikhailidis DP , Winder AF . Audit of elderly referrals to a lipid clinic. Atherosclerosis 1997; 130(suppl): S30.

Denke MA , Grundy SM . Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med 1990; 112: 780–92.

La Rosa JC , Applegate W , Crouse J.R. III Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study. Arch Intern Med 1994; 154: 529–39.

Scandinavian Simvastatin Survival group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9.

Sacks FM , Pfeffer MA , Moye LA The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–9.

The LIPID Study Group. Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: a randomised trial in patients with previous acute myocardial infarction and/or unstable angina pectoris. Am J Cardiol 1995; 76: 474–9.

Pyorala K , Pedersen TR , Kjekshus J , Faegerman O , Olsson AG , Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 1997; 20: 614–20.

Goldberg R , Sacks F , Howard B Diabetic response to pravastatin during the CARE Study (abstr). Circulation 1996; 94: S1: 540.

Miettinen H , Niemala M , Lehto S The FINMONICA AMI Register Group: short and long-term case fatality of myocardial infarction in diabetic and nondiabetic patients (abstr). Diabetologia 1994; 38(Suppl. 1): A20.

Shepherd J , Cobbe SM , Ford I Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301–7.

Krumholz HM , Radford MJ , Ellerbeck EF Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes. Circulation 1995; 92: 2841–7.